Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.
A strategic thought partner for your AI journey
Explore our latest insights and perspectives in these life science resources, news articles, and events.
Introduction The 2024 American Society of Hematology (ASH) Annual Meeting presented a wealth of data, unveiling the...
Putnam experts share observations on recent global trends in the rare disease space and recommend strategies to maximize opportunities.
Our experts shared key themes for #ASCO24 and now summarize the vital insights on antibody drug conjugates, radiopharmaceuticals, and bispecifics.
In recent years, we have observed increasing clinical development activity in autoimmune diseases, including for Myasthenia Gravis (MG).
Targeted radiopharmaceuticals are transforming cancer treatment and may become the ultimate focal therapy.
Personalized medicine is revolutionizing the field of oncology, and gastrointestinal (GI) cancers are at the forefront of this exciting development.
We’re sharing some spotlights to help support our clients and partners navigate ASH 2023.
ADCs continued to be a spotlight at ESMO 2023. The team shares its key value drivers and associated limitations.
The organization engaged Putnam to support the development of 10-year strategy, focused on continuous innovation across all aspects of the business.
Our cell and gene therapy experts offer a deep analysis on the current opportunities and challenges of cell therapies for solid tumors.
Putnam’s panel of CGT experts help the clients in clinical decision-making, product on-boarding, emerging technologies, and key market trends.
Looking to get in touch with an expert or team member?
Tell us how we can help.
